cGMP
Also known as: current Good Manufacturing Practice, current GMP, cGMPs
cGMP is the FDA's enforceable standard for how medicines must be manufactured, requiring that a drug's identity, strength, quality and purity are built into the product by the process rather than tested into it afterwards.
Why the "c" matters
The "c" stands for current, and it is the whole point of the term. GMP regulations are deliberately written as outcomes rather than prescriptions, so what counts as compliant moves as technology and industry practice move. A control strategy that satisfied an inspector fifteen years ago can be cited today without a single word of the regulation having changed. This is why firms cannot treat compliance as a fixed target reached once.
Where the requirements actually live
In the United States, cGMP for finished pharmaceuticals is codified in 21 CFR Parts 210 and 211. Part 210 sets the scope; Part 211 carries the substance — organisation and personnel, buildings and facilities, equipment, control of components, production and process controls, laboratory controls, records and reports, and returned or salvaged product.
Related regimes sit alongside it rather than inside it:
- 21 CFR Part 600s — biologics
- 21 CFR Part 4 — combination products
- ICH Q7 — active pharmaceutical ingredients
- EudraLex Volume 4 — the EU GMP guide, with its annexes
What inspectors are really testing
A cGMP inspection is not a document hunt. It is an attempt to answer one question: does this organisation understand and control its own process? The recurring citation themes are consistent year after year:
| Theme | What it looks like in practice |
|---|---|
| Inadequate investigations | A deviation closed as "operator error" with no root cause |
| Data integrity | Audit trails disabled, shared logins, results retested until they pass |
| Process validation | Validation treated as a one-time exercise, not a lifecycle |
| Contamination control | No holistic strategy tying the individual controls together |
| Quality unit independence | QA reporting into manufacturing, unable to say no |
The most common misunderstanding
cGMP is frequently read as "the rules for the factory floor." In practice it reaches every function whose decisions affect product quality — procurement qualifying a supplier, IT validating a system that stores batch records, engineering changing an HVAC setpoint. The quality unit's authority to reject a batch is meaningless if the decisions upstream of it were never controlled.
Go deeper
Related terms
Last reviewed 2026-08-05